A risky combination of medicines gets riskier when a patient’s prescriptions come from two doctors

Patients prescribed benzodiazepines and opioids by different providers 20% more likely to overdose, adding to already heightened risk.

2:05 PM

Author | Kara Gavin

drawing of pills in blue ink with lab note written on bottom right in yellow and navy blue
Michigan Medicine

For years, experts have warned of the risks of combining certain sedatives and prescription pain medications – for instance, Xanax and Vicodin, Valium and Norco, or Restoril and Percocet. Now, a new study shows that this combination is especially risky if multiple doctors prescribe the two different types of drugs to the same patient rather than the same doctor.

The two classes of drugs, called benzodiazepines and opioids, both act on the brain. Benzodiazepines are prescribed for anxiety, insomnia, and panic attacks, while opioids are prescribed for pain. Because both suppress the drive to breathe, past studies have shown a higher risk of overdose among patients who take opioids and benzodiazepines at the same time. 

The new study shows that the risk of overdose is even higher for patients who filled current prescriptions for both drugs, but whose prescription were written by two different providers. After adjusting for differences in patient characteristics and prescription dosing, the risk was 20% greater.

The finding comes from an analysis of private insurance and Medicare Advantage claims among more than 529,000 people over the age of 12 who had overlapping benzodiazepine and opioid prescriptions between late 2016 and the end of 2018. It's published in JAMA Network Open by a team from Michigan Medicine, the University of Michigan's academic medical center.

"We know that having overlapping opioid and benzodiazepine prescriptions is one of the strongest risk factors for overdose. Our findings suggest that the circumstances that lead to these overlapping prescriptions matter. For example, if a psychiatrist prescribes a benzodiazepine to a patient whose primary care doctor is already prescribing opioids, that may be more dangerous than if the primary care doctor writes both prescriptions," said Kao-Ping Chua, M.D., Ph.D., lead author of the new study.

Chua notes that the reasons for the increased risk aren't clear, but he speculates that it involves lack of coordination, a known risk factor for overdose. "Because of differing health record software, a doctor in one system might prescribe a benzodiazepine without being aware that the patient is being prescribed an opioid by a doctor in another system. This results in missed opportunities to co-prescribe naloxone and educate patients about the risk of overlapping opioid and benzodiazepine prescriptions," he said.

Chua notes that one solution would be to create an alert to co-prescribe naloxone in electronic health records anytime a doctor tries to prescribe an opioid to a patient who is prescribed a benzodiazepine by another doctor in the same system. He also notes that many states require prescribers to check a Prescription Drug Monitoring Program before prescribing controlled substances, which allows them to see if their patient is taking a medication that could clash with the one they're prescribing.  

However, Chua notes that these high-tech solutions would not be needed if doctors did a better job of taking a complete medical history. This includes a list of all medications patients are taking.

Overall, 44% of patients only had overlapping prescriptions from one prescriber and 28% only had overlapping prescriptions from multiple prescribers. Nearly 38% of the days of overlap between opioids and benzodiazepines involved prescriptions from multiple prescribers.

Overall, 1 in 231 patients had an overdose during a period of overlapping opioid and benzodiazepine prescriptions. Chua notes that this proportion would be even higher if the study had counted overdoses that resulted from leftover medications that weren't taken during this period.

Paper cited/DOI: JAMA Network Open. DOI:10.1001/jamanetworkopen.2021.20353


More Articles About: Lab Notes All Research Topics Acute Pain chronic pain Health Care Delivery, Policy and Economics Medication Guidelines Pain management
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Addiction is a lifelong disease and not a moral failing
On today’s The Fundamentals is Dr. Brummett, Professor at the University of Michigan where he serves as the Senior Associate Chair for Research in the Department of Anesthesiology. He has more than 280 publications, including articles in top journals such as JAMA, JAMA Surgery, Anesthesiology, and Annals of Surgery. He is the Co-Director of the Opioid Prescribing Engagement Network or OPEN at the University of Michigan, which aims to apply a preventative approach to the opioid epidemic in the US through appropriate prescribing after surgery, dentistry and emergency medicine. Moreover, he is the Co-Director of the cross-campus Opioid Research Institute, which was launched in the spring of 2023. He leads multiple NIH grants studying these concepts and receives funding from the Michigan Department of Health and Human Services, SAMHSA, CDC, and multiple foundations. You can learn more about Dr. Brummett here, and you can follow Dr. Brummett @drchadb and the department of anesthesiology @UMichAnesthesia on X.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Cannabis and psychedelics: stigmatized substances or powerful therapeutics?
Today on The Fundamentals is Dr. Kevin Boehnke, research assistant professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of cannabis and psychedelics. His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization.
stethoscope
Health Lab
More oversight of donated tissue products urgently needed, say experts and Michigan policymakers
A JAMA viewpoint outlines the tragic story of Shandra Eisenga, a patient who received spine surgery for back pain only to inexplicably contract tuberculosis.
woman holding face looking stressed on white couch in white shirt dark blue pants
Health Lab
Health costs top older adults’ list of concerns for people their age, poll finds
People over 50 of all backgrounds say they’re most concerned about various kinds of health costs affecting people their age, including insurance, prescriptions, medical care, dental care and home or longterm care.
kidneys blue yellow
Health Lab
Why personalized medicine is important in rare kidney disease
Building a comprehensive human kidney cell and tissue catalog could help develop more treatments for kidney disease.
Scientific illustration of gliobastoma cells in the brain
Health Lab
Path forward for glioblastoma treatment
Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment